Aromatase inhibitor side effects: do these TikTok remedies actually work?
Quick answer
Aromatase inhibitor-associated musculoskeletal syndrome (AIMSS) affects roughly 35-50% of postmenopausal breast cancer patients on AIs like anastrozole, letrozole, and exemestane, and is the leading cause of early discontinuation. The creator is addressing a real, clinically documented problem where evidence-based non-pharmacological options, particularly exercise and acupuncture, have demonstrated efficacy in RCTs. Black cohosh warrants caution in hormone-receptor-positive breast cancer patients despite one creator's oncologist recommending it, as theoretical estrogenic activity remains a concern that should be discussed individually with a treating oncologist.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @herbosombuddy actually say?
The creator, a breast cancer patient on aromatase inhibitors (AIs), compiled a list of non-opioid strategies for managing AI-related joint pain and musculoskeletal symptoms. She recommended exercise, acupuncture, diet changes, hydration with electrolytes, tart cherry juice, Claritin (loratadine), Vitamin D3/K2, B12 (specifically methylcobalamin), black cohosh, Bonafide products, sauna, meditation, GLP-1 medications, and switching AI brands or manufacturers. She was careful to note she is not telling people to stop their medications, and she credited her oncologist for the black cohosh suggestion. This is a patient sharing lived experience, not a clinician giving prescriptions.
That framing matters. AI-associated musculoskeletal syndrome (AIMSS) affects up to 50% of patients on aromatase inhibitors and is one of the top reasons for non-adherence. Anything that helps people stay on their cancer treatment is worth taking seriously.
Does the science back this up?
More than you might expect, though the evidence is uneven across her list. Exercise and acupuncture have the strongest data. The lifestyle suggestions are sensible but modest in effect. A few recommendations, particularly Claritin and tart cherry juice, have thin or anecdotal support for AIMSS specifically.
Exercise: A 2012 randomized controlled trial by Irwin et al. in the Journal of Clinical Oncology found that a year-long exercise intervention significantly reduced AI-related joint pain scores. This is one of the better-studied interventions on her list.
Acupuncture: A 2018 RCT by Hershman et al. published in JAMA Oncology found that acupuncture significantly reduced AI-related joint pain compared to sham acupuncture and waitlist controls. Insurance coverage is improving but still inconsistent.
Vitamin D: Multiple studies link low vitamin D to worsened AIMSS. A trial by Khan et al. (2012, Journal of Clinical Oncology) found that correcting vitamin D deficiency reduced joint pain in AI patients. This one has real support.
Loratadine (Claritin): There is one retrospective study suggesting antihistamines may reduce bone pain during G-CSF therapy, which is mechanistically different from AIMSS. Applying this to aromatase inhibitor pain is a stretch. The evidence for Claritin specifically in AIMSS is weak.
What did they get wrong (or right)?
She got several things right. The B12 advice, specifying methylcobalamin over cyanocobalamin, is pharmacologically reasonable, though for most people without absorption issues, the difference is modest. Recommending patients ask their pharmacy about switching manufacturers for the same AI is genuinely useful and underutilized advice, as inactive fillers can drive tolerability differences.
The black cohosh recommendation comes with a significant caveat she did not mention: black cohosh is generally avoided or approached with caution in hormone-receptor-positive breast cancer patients because of theoretical estrogenic activity, though evidence is mixed. The fact that her oncologist recommended it suggests a case-specific conversation happened, but presenting it without that warning to a general breast cancer audience is a gap. If you have ER-positive breast cancer, talk to your oncologist before taking black cohosh, full stop.
The GLP-1 mention is speculative. She framed it as something heard in a comment, not a claim, which is honest. But putting it on a list alongside established interventions gives it undeserved weight.
What should you actually know?
AIMSS is real, undertreated, and a genuine threat to treatment adherence, which directly affects cancer outcomes. A 2010 study by Hershman et al. in the Journal of Clinical Oncology found that patients who discontinued AIs had significantly worse breast cancer-specific survival. So non-adherence is not a minor issue.
The safest interventions on this list are exercise, acupuncture (with a qualified practitioner), vitamin D correction (get your levels tested first), hydration, and switching AI formulations or manufacturers under pharmacist guidance. These have either direct evidence or strong safety profiles.
Be cautious with black cohosh if you have hormone-receptor-positive breast cancer. Talk to your oncologist, not TikTok. The Bonafide products she mentions are marketed for menopause symptoms and are generally low-risk, but evidence for AIMSS specifically is limited. Sauna and meditation carry minimal risk and may help with pain and stress, even if the AIMSS-specific data is thin.
None of this replaces the conversation you need to have with your oncologist or a palliative care specialist who understands cancer treatment side effects.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Aromatase inhibitor side effects: do these TikTok remedies actually work?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Aromatase inhibitor side effects: do these TikTok remedies actually work? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Aromatase inhibitor-associated musculoskeletal syndrome (AIMSS) affects roughly 35-50% of postmenopausal breast cancer patients on AIs like anastrozole, letrozole, and exemestane, and is the leading cause of early discontinuation.
FormBlends verdict
Aromatase inhibitor-associated musculoskeletal syndrome (AIMSS) affects roughly 35-50% of postmenopausal breast cancer patients on AIs like anastrozole, letrozole, and exemestane, and is the leading cause of early discontinuation. The creator is addressing a real, clinically documented problem where evidence-based non-pharmacological options, particularly exercise and acupuncture, have demonstrated efficacy in RCTs. Black cohosh warrants caution in hormone-receptor-positive breast cancer patients despite one creator's oncologist recommending it, as theoretical estrogenic activity remains a concern that should be discussed individually with a treating oncologist.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Aromatase inhibitor-associated musculoskeletal syndrome (AIMSS) affects roughly 35-50% of postmenopausal breast cancer patients on AIs like anastrozole, letrozole, and exemestane, and is the leading cause of early discontinuation. The creator is addressing a real, clinically documented problem where evidence-based non-pharmacological options, particularly exercise and acupuncture, have demonstrated efficacy in RCTs. Black cohosh warrants caution in hormone-receptor-positive breast cancer patients despite one creator's oncologist recommending it, as theoretical estrogenic activity remains a concern that should be discussed individually with a treating oncologist.
- AIMSS affects up to 50% of patients on aromatase inhibitors and is the top reason for early discontinuation, which independently worsens breast cancer outcomes (Hershman et al., 2010, Journal of Clinical Oncology).
- Exercise has RCT-level evidence for reducing AI joint pain, not just general health benefit, making it the strongest recommendation on this list.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- AIMSS affects up to 50% of patients on aromatase inhibitors and is the top reason for early discontinuation, which independently worsens breast cancer outcomes (Hershman et al., 2010, Journal of Clinical Oncology).
- Exercise has RCT-level evidence for reducing AI joint pain, not just general health benefit, making it the strongest recommendation on this list.
- Acupuncture beat sham acupuncture in a 2018 JAMA Oncology RCT specifically for AI-associated joint pain, which means it is more than placebo.
- Vitamin D correction has direct evidence in this population, but you need a blood test first to know whether you are actually deficient before supplementing.
- Claritin for AI pain is based on anecdote and a mechanistically unrelated study, not clinical evidence in breast cancer patients.
- Black cohosh should not be taken without oncologist approval in hormone-receptor-positive breast cancer, regardless of who recommended it in someone else's individual case.
- Switching AI manufacturers within the same drug class is a legitimate, underused strategy because inactive fillers vary and can drive tolerability differences, ask your pharmacist.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
HerBosomBuddy · TikTok creator
5.9K views on this video
Replying to @Dunia A I know not everyone can go off these meds so here’s a list of things to try😊 Exercise, acupuncture, limiting sugar/processed foods, staying hydrated (maybe add clean electrolytes), tart cherry juice, Claritin, Vitamin D3/K2, Vitamin B12, black cohosh, Bonafide products, sauna, meditation/box breathing, GLP-1, switching to another AI or switching manufacturers of your current medication. Please share with someone who might need this. Hope it helps🩷 #breastcancer #aromatasei
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by HerBosomBuddy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.